For patients with atrial fibrillation, the risk of stroke or heart attack from stopping anticoagulants usually outweighs the risk of bleeding, according to new findings from the University of Bath.

AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback.

Background: A potential drug interaction exists between oral corticosteroids and warfarin, but there is limited documentation. Objective: To evaluate the potential drug interaction between oral ...

Our study found that the INR was increased in the over-whelming majority (91%) of patients following concomitant use of warfarin and short-term oral corticosteroids. Since most target INR ranges ...

This leaflet answers some common questions about COSAMIDE 50. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines ...